ImevaX's Grant

ImevaX raised a round of funding on October 14, 2014. Investors include Bundesministerium fur Bildung und Forschung.

ImevaX is a biopharmaceutical company founded in 2014 based in Munich/Germany. The company is a spin-out of Technische Universitat Munchen (TUM) and sponsored with funds from the German Ministry of Ed…

Articles about ImevaX's Grant: